“Onset of Clinical Response With Deucravacitinib in Patients With Moderate to Severe Scalp Psoriasis: A Post Hoc Analysis of the Phase 3b 4 PSORIATYK SCALP Trial”. 2025. SKIN The Journal of Cutaneous Medicine 9 (2): s539. https://doi.org/10.25251/skin.10.supp.539.